Robert Delage

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

The Impact of UGT1A8, UGT1A9, and UGT2B7 Genetic Polymorphisms on the Pharmacokinetic Profile of Mycophenolic Acid After a Single Oral Dose in Healthy Volunteers

Éric Lévesque, Robert Delage, Marie‐Odile Benoit‐Biancamano et al. · Clinical Pharmacology & Therapeutics · 2007 · 158 citations

Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia

Robert Delage, RJ Soiffer, Keith Dear et al. · Blood · 1991 · 100 citations · Full text

Anti-Erythropoietin Antibody-Mediated Pure Red Cell Aplasia after Treatment with Recombinant Erythropoietin Products

Denis Cournoyer, Edwin B. Toffelmire, George A. Wells et al. · Journal of the American Society of Nephrology · 2004 · 77 citations

Immunology, Blood Cell, Pathology +20

Quantitative Analysis of Cytomegalovirus (CMV) Viremia Using the pp65 Antigenemia Assay and the COBAS AMPLICOR CMV MONITOR PCR Test after Blood and Marrow Allogeneic Transplantation

Guy Boivin, Robert Bélanger, Robert Delage et al. · Journal of Clinical Microbiology · 2000 · 67 citations · Full text